Jyong Biotech Ltd. (MENS) vs Yarrow Bioscience, Inc (YARW)

Jyong Biotech Ltd. and Yarrow Bioscience, Inc are both Biotechnology companies. Yarrow Bioscience, Inc is the larger, with a market value of $147.2M against $133.6M — 1.1× the size. Across the 4 metrics below, Jyong Biotech Ltd. leads on 2 and Yarrow Bioscience, Inc on 2.

Valuation

Metric MENS YARW Biotechnology median
P/E — n/m 10.60
P/S — 27.77 9.40
P/B n/m 0.61 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 118.48 9.02
Earnings yield — (138.76%) (32.88%)
Free cash flow yield — (127.91%) (23.13%)

Profitability

Metric MENS YARW Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — (4,134.44%) 0.00%
Net margin — (3,881.54%) 0.00%
Free cash flow margin — (3,513.07%) 0.00%
Return on equity — (61.40%) (51.96%)
Return on assets — (54.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MENS YARW Biotechnology median
Revenue growth (TTM) — 1.26% 6.76%
EPS growth (last fiscal year) (42.18%) 32.26% 29.88%
Revenue growth, 5-year CAGR — (51.39%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MENS YARW Biotechnology median
Debt to equity (0.74) 0.00 0.00
Current ratio 0.45 15.26 4.97
Net debt to EBITDA (6.89) 0.95 1.01

Dividend

Metric MENS YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric MENS YARW Biotechnology median
Market cap 133.62m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack